Hanmi Financial Corporation

Company Details:

Company Symbol: HAFC
Sector: Financial Institutions
Company Rating: buy
URL: http://www.hanmi.com

Related Research

  • 04/20/12 Morning Note B. Riley & Co. Morning Notes: CVBF, CYS, HAFC, SYMM, TIVO, UMPQ
  • 04/20/12 Update HAFC (Buy; $13.00 PT): Reports Solid Profitability Despite Temporary SBA Loan Sale Setback; Reducing EPS Estimates on Lower NIM Projection; Rated…
  • 04/18/12 Morning Note B. Riley & Co. Morning Notes: ACW, ARR, BPOP, CATY, CHRS, CREE, CSGP, CYN, GBCI, HAFC, IMAX, KTOS, LOOP, RKN, RLD, YHOO
  • 03/21/12 Morning Note B. Riley & Co. Morning Notes: DSW, HAFC, IMAX, KKD, MYGN
  • 03/21/12 Update HAFC (Buy; $13.00 PT): Event: Management Meetings Lead to Greater Confidence and Increased EPS Estimates; Raising Target by $3.00 and Reiterating…
  • 01/20/12 Morning Note B. Riley & Co. Morning Notes: CVBF, GOOG, HAFC, NFLX, NTCT
  • 01/20/12 Update HAFC (Buy; $10.00 PT): Reports Solid Profitability and Asset Quality Improvements; Reducing EPS Estimates for Slower Reserve Release; Rated “Buy”…
  • 01/17/12 Morning Note B. Riley & Co. Morning Notes: 14th Annual ICR XChange Conference: Notes and Highlights, CIDM, CKEC, CNK, CSTR, CYN, EWBC, HAFC, PVSW, Q4'11 Earnings…
  • 12/19/11 Morning Note B. Riley & Co. Morning Notes: CKEC, CNK, CSTR, DRL, FINL, HAFC, PII, RGC
  • 11/15/11 Update HAFC (Buy: $1.25): Launches $70M Stock Offering; Reducing EPS Estimates but Raising Target Price and Upgrading Our Rating to “Buy”
  • 11/15/11 Morning Note B. Riley & Co. Morning Notes: API, CMLS, HAFC, SPA
  • 10/24/11 Morning Note B. Riley & Co. Morning Notes: ACW, CYN, EXAR, HAFC, IIVI, KONA, PACW, PFBC, PPC, PRGX, PRSP, PVSW, RNST, TBBK
  • 10/24/11 Update HAFC (Neutral; $1.00): EPS Miss Belies Strong Improvements. Raising EPS Estimates While Reaffirming “Neutral” Rating and $1.00 Target
  • 10/11/11 Morning Note B. Riley & Co. Morning Notes: ADPT, GAMR, HAFC, KEYN, SIMO, SKX
  • 10/10/11 Initiation of Coverage HAFC (Neutral; $1.00): Recent Results are Encouraging, but Much More Work Ahead. Initiating Coverage with a “Neutral” Rating